AIMC Topic: Drug Discovery

Clear Filters Showing 801 to 810 of 1689 articles

On the Frustration to Predict Binding Affinities from Protein-Ligand Structures with Deep Neural Networks.

Journal of medicinal chemistry
Accurate prediction of binding affinities from protein-ligand atomic coordinates remains a major challenge in early stages of drug discovery. Using modular message passing graph neural networks describing both the ligand and the protein in their free...

Artificial intelligence in virtual screening: Models versus experiments.

Drug discovery today
A typical drug discovery project involves identifying active compounds with significant binding potential for selected disease-specific targets. Experimental high-throughput screening (HTS) is a traditional approach to drug discovery, but is expensiv...

Data considerations for predictive modeling applied to the discovery of bioactive natural products.

Drug discovery today
Natural products (NPs) constitute a large reserve of bioactive compounds useful for drug development. Recent advances in high-throughput technologies facilitate functional analysis of therapeutic effects and NP-based drug discovery. However, the larg...

Emerging frontiers in virtual drug discovery: From quantum mechanical methods to deep learning approaches.

Current opinion in chemical biology
Virtual screening-based approaches to discover initial hit and lead compounds have the potential to reduce both the cost and time of early drug discovery stages, as well as to find inhibitors for even challenging target sites such as protein-protein ...

Bench to bedside: The ambitious goal of transducing medicinal chemistry from the lab to the clinic.

Bioorganic & medicinal chemistry letters
This paper deals with a critical examination on the possibility of quantitatively predicting the in vivo activity of new chemical entities (NCEs) by making use of in silico and in vitro data including three-dimensional structure of drug-target comple...

Artificial intelligence in cancer target identification and drug discovery.

Signal transduction and targeted therapy
Artificial intelligence is an advanced method to identify novel anticancer targets and discover novel drugs from biology networks because the networks can effectively preserve and quantify the interaction between components of cell systems underlying...

Identifying Protein Features and Pathways Responsible for Toxicity Using Machine Learning and Tox21: Implications for Predictive Toxicology.

Molecules (Basel, Switzerland)
Humans are exposed to numerous compounds daily, some of which have adverse effects on health. Computational approaches for modeling toxicological data in conjunction with machine learning algorithms have gained popularity over the last few years. Mac...

In silico prediction of potential drug-induced nephrotoxicity with machine learning methods.

Journal of applied toxicology : JAT
In recent years, drug-induced nephrotoxicity has been one of the main reasons for the failure of drug development. Early prediction of the nephrotoxicity for drug candidates is critical to the success of clinical trials. Therefore, it is very importa...

Modern machine learning for tackling inverse problems in chemistry: molecular design to realization.

Chemical communications (Cambridge, England)
The discovery of new molecules and materials helps expand the horizons of novel and innovative real-life applications. In pursuit of finding molecules with desired properties, chemists have traditionally relied on experimentation and recently on comb...

Machine learning approaches and their applications in drug discovery and design.

Chemical biology & drug design
This review is focused on several machine learning approaches used in chemoinformatics. Machine learning approaches provide tools and algorithms to improve drug discovery. Many physicochemical properties of drugs like toxicity, absorption, drug-drug ...